We are looking for an experienced Gross to Net specialist to support a biotech organization in New Jersey as it prepares for a major commercial milestone. This contract position will play a central role in establishing a scalable gross-to-net framework, strengthening financial controls, and guiding launch readiness activities. The ideal candidate brings deep accounting expertise and can translate complex rebate, pricing, and reserve considerations into practical processes that support accurate financial reporting and compliance.
Responsibilities:
- Build and implement a complete gross-to-net operating model in advance of product launch, including reserve methodologies, accrual logic, and close procedures.
- Oversee the full range of gross-to-net components such as government rebate programs, 340B activity, chargebacks, commercial discounts, patient support offerings, distribution fees, returns, and payment-related deductions.
- Evaluate current workflows to identify control weaknesses, then introduce reconciliations, review checkpoints, and documentation that improve accuracy and accountability.
- Partner with external vendors involved in government pricing and related calculations, ensuring deliverables are accurate, timely, and aligned with internal expectations.
- Establish a compliance-focused approach that supports reporting obligations, audit readiness, and adherence to applicable regulatory standards.
- Develop forecasting and analytical models that explain the relationship between gross sales and net sales, and present key drivers of financial variances to business leaders.
- Contribute gross-to-net assumptions to planning cycles by aligning financial expectations with launch strategy, pricing decisions, and anticipated payer mix.
- Create standard operating procedures, process maps, and detailed reference materials to enable repeatable execution and future scale.
- Train internal accounting and shared services teams on gross-to-net activities, month-end expectations, and ongoing process ownership.
- Strong experience leading Gross to Net accounting activities within the life sciences, biotech, or pharmaceutical industry.
- Demonstrated ability to support month-end close processes, including journal entries, reconciliations, and reserve analysis.
- Solid understanding of general ledger activity and its connection to gross-to-net reporting and financial statement impact.
- Experience working with audits and maintaining documentation that supports financial and compliance review requirements.
- Proven ability to design new processes and controls in environments preparing for commercialization or rapid growth.
- Knowledge of government pricing, rebate structures, chargebacks, distribution fees, and related pharmaceutical contracting elements.
- Strong analytical and communication skills, with the ability to explain complex financial results to cross-functional stakeholders.